Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meditation | 5 | 2022 | 242 | 1.440 |
Why?
|
| Citalopram | 4 | 2016 | 403 | 1.260 |
Why?
|
| Depressive Disorder, Major | 12 | 2022 | 4644 | 1.130 |
Why?
|
| Dementia | 4 | 2022 | 2518 | 0.840 |
Why?
|
| Antidepressive Agents | 4 | 2019 | 2838 | 0.540 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2022 | 1004 | 0.500 |
Why?
|
| Hydrocortisone | 1 | 2019 | 1826 | 0.390 |
Why?
|
| Caregivers | 3 | 2022 | 2094 | 0.390 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 247 | 0.380 |
Why?
|
| Memory | 1 | 2019 | 2174 | 0.340 |
Why?
|
| Arachnoid Cysts | 1 | 2008 | 59 | 0.300 |
Why?
|
| Arthroplasty, Replacement | 1 | 2011 | 339 | 0.300 |
Why?
|
| Meningomyelocele | 1 | 2008 | 165 | 0.280 |
Why?
|
| Yoga | 2 | 2023 | 253 | 0.270 |
Why?
|
| Spinal Cord Compression | 1 | 2008 | 235 | 0.270 |
Why?
|
| Treatment Outcome | 9 | 2022 | 63114 | 0.260 |
Why?
|
| Ketamine | 2 | 2022 | 500 | 0.260 |
Why?
|
| Depression | 7 | 2023 | 7766 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2003 | 51 | 0.230 |
Why?
|
| Decompression, Surgical | 1 | 2008 | 594 | 0.220 |
Why?
|
| Heart Rate | 1 | 2014 | 4091 | 0.220 |
Why?
|
| Signal Detection, Psychological | 2 | 2013 | 85 | 0.210 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2003 | 346 | 0.200 |
Why?
|
| Pulmonary Circulation | 1 | 2003 | 739 | 0.180 |
Why?
|
| Delirium | 1 | 2011 | 1609 | 0.180 |
Why?
|
| Epinephrine | 1 | 2003 | 792 | 0.170 |
Why?
|
| Riluzole | 1 | 2019 | 55 | 0.170 |
Why?
|
| Olfaction Disorders | 1 | 2022 | 222 | 0.170 |
Why?
|
| Remission Induction | 3 | 2016 | 2386 | 0.170 |
Why?
|
| Vasculitis | 1 | 2003 | 519 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4245 | 0.160 |
Why?
|
| Pilot Projects | 3 | 2023 | 8324 | 0.150 |
Why?
|
| Pituitary-Adrenal System | 1 | 2019 | 553 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3086 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2019 | 703 | 0.130 |
Why?
|
| Resilience, Psychological | 1 | 2021 | 676 | 0.120 |
Why?
|
| Neurology | 1 | 2022 | 763 | 0.120 |
Why?
|
| Bleomycin | 2 | 2004 | 512 | 0.100 |
Why?
|
| Humans | 28 | 2023 | 744343 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2022 | 2147 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 9959 | 0.100 |
Why?
|
| Anxiety | 2 | 2017 | 4297 | 0.100 |
Why?
|
| Hematocrit | 1 | 2011 | 636 | 0.090 |
Why?
|
| Middle Aged | 13 | 2023 | 213383 | 0.090 |
Why?
|
| Female | 19 | 2023 | 380194 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15295 | 0.080 |
Why?
|
| Age Factors | 2 | 2019 | 18370 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 2 | 2004 | 530 | 0.080 |
Why?
|
| Male | 16 | 2023 | 350118 | 0.080 |
Why?
|
| Headache | 1 | 2016 | 1226 | 0.080 |
Why?
|
| Morphine | 1 | 2011 | 657 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 12804 | 0.070 |
Why?
|
| Pneumonia | 3 | 2004 | 2133 | 0.070 |
Why?
|
| Adult | 12 | 2023 | 214055 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 6038 | 0.070 |
Why?
|
| Subthalamic Nucleus | 1 | 2009 | 184 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2022 | 2274 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2011 | 1101 | 0.070 |
Why?
|
| Ablation Techniques | 1 | 2008 | 249 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2014 | 2682 | 0.060 |
Why?
|
| ROC Curve | 1 | 2013 | 3527 | 0.060 |
Why?
|
| Granulocytes | 2 | 2004 | 548 | 0.060 |
Why?
|
| Brain | 5 | 2022 | 26385 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 35421 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 6993 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19905 | 0.060 |
Why?
|
| Electroencephalography | 2 | 2016 | 6150 | 0.060 |
Why?
|
| Aged | 7 | 2022 | 163280 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5078 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 15540 | 0.060 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2003 | 226 | 0.060 |
Why?
|
| Cortisone | 1 | 2003 | 89 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2017 | 4043 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2008 | 582 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2022 | 6600 | 0.050 |
Why?
|
| Lymphocyte Subsets | 1 | 2003 | 315 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2008 | 1091 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6770 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2014 | 3748 | 0.050 |
Why?
|
| Cervical Vertebrae | 1 | 2008 | 975 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.050 |
Why?
|
| Interleukin-10 | 2 | 2004 | 1200 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3396 | 0.050 |
Why?
|
| Maintenance | 1 | 2020 | 25 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8037 | 0.050 |
Why?
|
| Pain | 1 | 2016 | 4986 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2014 | 6442 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 692 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 40075 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8642 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2002 | 579 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7785 | 0.040 |
Why?
|
| Chemokines | 1 | 2003 | 970 | 0.040 |
Why?
|
| Empathy | 1 | 2023 | 474 | 0.040 |
Why?
|
| Motor Activity | 1 | 2009 | 2714 | 0.040 |
Why?
|
| Radiosurgery | 1 | 2008 | 1329 | 0.040 |
Why?
|
| Reoperation | 1 | 2008 | 4201 | 0.040 |
Why?
|
| Aging | 1 | 2017 | 8664 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 3057 | 0.040 |
Why?
|
| Glutathione Disulfide | 1 | 2017 | 29 | 0.040 |
Why?
|
| F2-Isoprostanes | 1 | 2017 | 35 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14722 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12026 | 0.040 |
Why?
|
| Inflammation | 1 | 2016 | 10638 | 0.040 |
Why?
|
| Monocytes | 2 | 2003 | 2596 | 0.040 |
Why?
|
| Recurrence | 1 | 2008 | 8340 | 0.030 |
Why?
|
| Neurophysiology | 1 | 2016 | 142 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 3674 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2009 | 2775 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 589 | 0.030 |
Why?
|
| Lung | 2 | 2004 | 9856 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77449 | 0.030 |
Why?
|
| Amygdala | 1 | 2021 | 1315 | 0.030 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 503 | 0.030 |
Why?
|
| Psychometrics | 1 | 2022 | 3002 | 0.030 |
Why?
|
| Outpatients | 1 | 2020 | 1486 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 13881 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 29063 | 0.030 |
Why?
|
| tau Proteins | 1 | 2022 | 1868 | 0.030 |
Why?
|
| Chemokines, CC | 2 | 2004 | 291 | 0.030 |
Why?
|
| Emotions | 1 | 2023 | 2661 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4933 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25043 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2004 | 768 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2004 | 21827 | 0.020 |
Why?
|
| Gene Expression | 1 | 2003 | 7799 | 0.020 |
Why?
|
| Young Adult | 4 | 2021 | 56430 | 0.020 |
Why?
|
| Patient Selection | 1 | 2022 | 4215 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3587 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2022 | 6196 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3218 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 25625 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
| Infant | 1 | 2008 | 35136 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6234 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2021 | 6669 | 0.020 |
Why?
|
| Risk Factors | 1 | 2011 | 72290 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2009 | 2375 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 2002 | 116 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 2002 | 129 | 0.010 |
Why?
|
| Mice | 3 | 2004 | 81183 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 209 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
| Action Potentials | 1 | 2009 | 1806 | 0.010 |
Why?
|
| Animals | 4 | 2009 | 168757 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6365 | 0.010 |
Why?
|
| Macrophages, Alveolar | 1 | 2002 | 407 | 0.010 |
Why?
|
| Eosinophils | 1 | 2004 | 955 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2004 | 14557 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2002 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2004 | 2617 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 2362 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39050 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2002 | 1836 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 4026 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2002 | 3206 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3768 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 2133 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 57776 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 3200 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 85781 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 7181 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2008 | 53288 | 0.000 |
Why?
|
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_